The global Saccharomyces Cerevisiae Market Comprehensive Study analyzes and forecasts the market size across 6 regions and 24 countries for diverse segments -By Type (Yeast Extracts, Yeast Autolysates, Yeast Beta-Glucan, Others), By Application (Food, Bakery, Functional Foods, Savory, Beverages, Feed, Others)
In 2024, the market for Saccharomyces cerevisiae, commonly known as baker's yeast or brewer's yeast, is experiencing robust growth driven by its versatile applications in food, beverage, pharmaceutical, and biotechnology industries. Saccharomyces cerevisiae is a single-celled fungus widely utilized for its fermentation capabilities, which play a critical role in the production of bread, beer, wine, and biofuels. Additionally, Saccharomyces cerevisiae serves as a valuable ingredient in the manufacturing of dietary supplements, probiotics, and animal feed additives due to its rich nutritional profile and potential health benefits. With advancements in biotechnology and genetic engineering, researchers are exploring novel uses for Saccharomyces cerevisiae, such as bioremediation, pharmaceutical production, and even as a platform for vaccine development. As consumer demand for natural, sustainable, and functional ingredients continues to rise, Saccharomyces cerevisiae remains a cornerstone of innovation and productivity across diverse industries, driving market expansion and technological advancements.
The market report analyses the leading companies in the industry including AB Mauri, Algist Bruggeman, Alltech Inc, Angel Yeast, Bio-Strath, DCL Yeast, Kerry Group plc, Kothari Fermentation and Biochem, Lallemand, Leiber, Lesaffre Group, Ohly GmbH, Pakmaya, and Others.
The market for Saccharomyces Cerevisiae is experiencing a notable trend driven by the rising demand for natural and clean label ingredients in food and beverage products. Saccharomyces cerevisiae, commonly known as baker's yeast or brewer's yeast, is valued for its role in fermentation processes and its ability to impart desirable flavor and texture characteristics to various food and beverage applications. This trend is fueled by consumers' growing preference for products made with recognizable and minimally processed ingredients, as well as the food industry's efforts to meet clean label standards and address consumer concerns about artificial additives and preservatives. As a natural and versatile ingredient, Saccharomyces cerevisiae is well-positioned to capitalize on this trend and meet the demand for clean label solutions in the food and beverage market.
The market for Saccharomyces Cerevisiae is primarily driven by the growth of functional foods and beverages fortified with probiotics, vitamins, and other bioactive compounds. Saccharomyces cerevisiae is widely recognized for its probiotic properties and potential health benefits, including supporting digestive health, boosting immune function, and enhancing nutrient absorption. As consumers become more health-conscious and seek products that offer functional benefits beyond basic nutrition, there is a growing demand for functional ingredients like Saccharomyces cerevisiae in food and beverage formulations. This driver is reinforced by the increasing prevalence of lifestyle-related health concerns such as gut health disorders, immune system deficiencies, and nutrient deficiencies, driving the demand for functional foods and beverages fortified with Saccharomyces cerevisiae and other beneficial ingredients.
The market for Saccharomyces Cerevisiae presents a significant opportunity for expansion into nutritional supplements and wellness products targeting diverse consumer needs and health goals. Companies can leverage the probiotic and nutritional properties of Saccharomyces cerevisiae to develop a wide range of dietary supplements, including probiotic capsules, immune support formulas, and digestive health supplements. Additionally, there are opportunities to explore innovative delivery formats such as powders, gummies, and liquid shots to enhance convenience and consumer appeal. By tapping into the growing market for health and wellness products, companies can diversify their product portfolios, reach new consumer segments, and drive revenue growth in the competitive nutritional supplement market.
In the Saccharomyces Cerevisiae market, the "Yeast Extracts" segment is the largest, commanding significant prominence for several compelling reasons. Yeast extracts are highly versatile ingredients widely used in food, beverage, and pharmaceutical industries for their rich flavor profile, nutritional benefits, and functional properties. As natural flavor enhancers, yeast extracts add depth and complexity to various food products, including soups, sauces, snacks, and savory dishes. Further, yeast extracts are valued for their high content of amino acids, vitamins, and minerals, making them a popular choice in nutritional supplements and health products. Additionally, the growing demand for clean-label and natural ingredients drives the adoption of yeast extracts as alternatives to artificial flavorings and additives. With their widespread applications and proven efficacy in enhancing taste and nutritional value, the Yeast Extracts segment remains at the forefront of the Saccharomyces Cerevisiae market, shaping the landscape of food and pharmaceutical formulations worldwide.
Among the segments delineated in the Saccharomyces Cerevisiae market, the "Functional Foods" segment is the fastest-growing, propelled by several key factors. Functional foods fortified with Saccharomyces Cerevisiae offer consumers enhanced nutritional value and health benefits, catering to the growing demand for wellness-focused products. Saccharomyces Cerevisiae is rich in vitamins, minerals, and bioactive compounds, making it an ideal ingredient for boosting immune function, promoting gut health, and supporting overall well-being. Further, the rising consumer awareness of the link between diet and health drives the demand for functional foods with added nutritional and functional ingredients like Saccharomyces Cerevisiae. Additionally, advancements in food processing technologies and formulation techniques enable manufacturers to develop innovative functional food products tailored to specific health concerns and dietary preferences. With its multifaceted benefits and versatility in food applications, the Functional Foods segment is poised to sustain its rapid growth trajectory, reshaping the landscape of the Saccharomyces Cerevisiae market towards functional and health-enhancing food offerings.
By Type
Yeast Extracts
Yeast Autolysates
Yeast Beta-Glucan
Others
By Application
Food
Bakery
Functional Foods
Savory
Beverages
Feed
Others
Countries Analyzed
North America (US, Canada, Mexico)
Europe (Germany, UK, France, Spain, Italy, Russia, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Australia, South East Asia, Rest of Asia)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)
AB Mauri
Algist Bruggeman
Alltech Inc
Angel Yeast
Bio-Strath
DCL Yeast
Kerry Group plc
Kothari Fermentation and Biochem
Lallemand
Leiber
Lesaffre Group
Ohly GmbH
Pakmaya
*- List Not Exhaustive
Chapter 1. TABLE OF CONTENTS
Chapter 2. Introduction to Saccharomyces Cerevisiae Market
2.1. Market Overview
2.2. Key Statistics and Report Highlights
2.3. Scope of the Comprehensive Study
2.3.1. Market Definition
2.3.2 Countries and Regions Covered
2.3.3 Research Objective
2.3.4 Units, Currency, and Conversions
2.3.5 Industry Value Chain
2.4. Key Market Segments
2.5. Key Companies
2.6. Study Period
Chapter 3. Strategic Analysis Review
3.1. Saccharomyces Cerevisiae Pricing Analysis and Forecast
3.2. Porter’s Five Forces
3.3. Market Ecosystem
3.4. SWOT Analysis
3.5. Regulatory Scenario
3.3. Effects of Inflation, Russia-Ukraine War, moderating economic growth, and other macroeconomic factors
Chapter 4. Competitive Landscape
4.1. Market Share Analysis
4.1.1. Global Saccharomyces Cerevisiae Market Share by Company, 2023
4.1.2. Product Offerings of Leading Saccharomyces Cerevisiae Companies
4.2. Market Entropy
4.2.1. New Product Launches in the Industry
4.2.2. Mergers, Acquisitions, Joint ventures, and Partnerships
4.3. Key Strategies and Best Practices
Chapter 5. Global Market Projections: Best, Reference, and Low Case Scenarios
5.1. Growth Analysis- Case Scenario Definitions
5.2. Low Growth Case Scenario Forecasts
5.3. Reference Growth Case Scenario Forecasts
5.4. High Growth Case Scenario Forecasts
Chapter 6. Market Dynamics
6.1. Saccharomyces Cerevisiae Market Drivers
6.2. Saccharomyces Cerevisiae Market Challenges
6.6. Saccharomyces Cerevisiae Market Opportunities
6.4. Saccharomyces Cerevisiae Market Trends
Chapter 7. Global Saccharomyces Cerevisiae Market Outlook Trends
7.1. Global Saccharomyces Cerevisiae Revenue (USD Million) and CAGR (%) by Type (2021-2032)
7.2. Global Saccharomyces Cerevisiae Revenue (USD Million) and CAGR (%) by Application (2021-2032)
7.3. Global Saccharomyces Cerevisiae Revenue (USD Million) and CAGR (%) by Product (2021-2032)
By Type
Yeast Extracts
Yeast Autolysates
Yeast Beta-Glucan
Others
By Application
Food
Bakery
Functional Foods
Savory
Beverages
Feed
Others
Chapter 8. Global Saccharomyces Cerevisiae Regional Analysis and Outlook
8.1. Global Saccharomyces Cerevisiae Revenue (USD Million) By Regions (2021- 2032)
8.2. North America Saccharomyces Cerevisiae Revenue (USD Million) by Country (2021-2032)
8.2.1. United States Saccharomyces Cerevisiae Regional Analysis and Outlook
8.2.2. Canada Saccharomyces Cerevisiae Regional Analysis and Outlook
8.2.3. Mexico Saccharomyces Cerevisiae Regional Analysis and Outlook
8.3. Europe Saccharomyces Cerevisiae Revenue (USD Million), by Country (2021-2032)
8.3.1. Germany Saccharomyces Cerevisiae Regional Analysis and Outlook
8.3.2. France Saccharomyces Cerevisiae Regional Analysis and Outlook
8.3.3. United Kingdom Saccharomyces Cerevisiae Regional Analysis and Outlook
8.3.4. Spain Saccharomyces Cerevisiae Regional Analysis and Outlook
8.3.5. Italy Saccharomyces Cerevisiae Regional Analysis and Outlook
8.3.6. Russia Saccharomyces Cerevisiae Regional Analysis and Outlook
8.3.7. Rest of Europe Saccharomyces Cerevisiae Regional Analysis and Outlook
8.4. Asia Pacific Saccharomyces Cerevisiae Revenue (USD Million) by Country (2021-2032)
8.4.1. China Saccharomyces Cerevisiae Regional Analysis and Outlook
8.4.2. Japan Saccharomyces Cerevisiae Regional Analysis and Outlook
8.4.3. India Saccharomyces Cerevisiae Regional Analysis and Outlook
8.4.4. South Korea Saccharomyces Cerevisiae Regional Analysis and Outlook
8.4.5. Australia Saccharomyces Cerevisiae Regional Analysis and Outlook
8.4.6. South East Asia Saccharomyces Cerevisiae Regional Analysis and Outlook
8.4.7. Rest of Asia Pacific Saccharomyces Cerevisiae Regional Analysis and Outlook
8.5. South America Saccharomyces Cerevisiae Revenue (USD Million), by Country (2021-2032)
8.5.1. Brazil Saccharomyces Cerevisiae Regional Analysis and Outlook
8.5.2. Argentina Saccharomyces Cerevisiae Regional Analysis and Outlook
8.5.3. Rest of South America Saccharomyces Cerevisiae Regional Analysis and Outlook
8.6. Middle East and Africa Saccharomyces Cerevisiae Revenue (USD Million) by Country (2021-2032)
8.6.1. Middle East Saccharomyces Cerevisiae Regional Analysis and Outlook
8.6.2. Africa Saccharomyces Cerevisiae Regional Analysis and Outlook
Chapter 9. North America Saccharomyces Cerevisiae Analysis and Outlook
9.1. North America Saccharomyces Cerevisiae Revenue (USD Million) by Segments (2021-2032)
9.1.1. North America Saccharomyces Cerevisiae Revenue (USD Million) by Type (2021-2032)
9.1.2. North America Saccharomyces Cerevisiae Revenue (USD Million) by Application (2021-2032)
9.1.3. North America Saccharomyces Cerevisiae Revenue (USD Million) by Product (2021-2032)
By Type
Yeast Extracts
Yeast Autolysates
Yeast Beta-Glucan
Others
By Application
Food
Bakery
Functional Foods
Savory
Beverages
Feed
Others
Chapter 10. Europe Saccharomyces Cerevisiae Analysis and Outlook
10.1. Europe Saccharomyces Cerevisiae Revenue (USD Million), by Segments (USD Million) (2021-2032)
10.1.1. Europe Saccharomyces Cerevisiae Revenue (USD Million) by Type (2021-2032)
10.1.2. Europe Saccharomyces Cerevisiae Revenue (USD Million) by Application (2021-2032)
10.1.3. Europe Saccharomyces Cerevisiae Revenue (USD Million) by Product (2021-2032)
By Type
Yeast Extracts
Yeast Autolysates
Yeast Beta-Glucan
Others
By Application
Food
Bakery
Functional Foods
Savory
Beverages
Feed
Others
Chapter 11. Asia Pacific Saccharomyces Cerevisiae Analysis and Outlook
11.1. Asia Pacific Saccharomyces Cerevisiae Revenue (USD Million), and Revenue (USD Million) by Segments (2021-2032)
11.1.1. Asia Pacific Saccharomyces Cerevisiae Revenue (USD Million) by Type (2021-2032)
11.1.2. Asia Pacific Saccharomyces Cerevisiae Revenue (USD Million) by Application (2021-2032)
11.1.3. Asia Pacific Saccharomyces Cerevisiae Revenue (USD Million) by Product (2021-2032)
By Type
Yeast Extracts
Yeast Autolysates
Yeast Beta-Glucan
Others
By Application
Food
Bakery
Functional Foods
Savory
Beverages
Feed
Others
Chapter 12. South America Saccharomyces Cerevisiae Analysis and Outlook
12.1. South America Saccharomyces Cerevisiae Revenue (USD Million), by Segments (2021-2032)
12.1.1. South America Saccharomyces Cerevisiae Revenue (USD Million) by Type (2021-2032)
12.1.2. South America Saccharomyces Cerevisiae Revenue (USD Million) by Application (2021-2032)
12.1.3. South America Saccharomyces Cerevisiae Revenue (USD Million) by Product (2021-2032)
By Type
Yeast Extracts
Yeast Autolysates
Yeast Beta-Glucan
Others
By Application
Food
Bakery
Functional Foods
Savory
Beverages
Feed
Others
Chapter 13. Middle East and Africa Saccharomyces Cerevisiae Analysis and Outlook
13.1. Middle East and Africa Saccharomyces Cerevisiae Revenue (USD Million), by Segments (2021-2032)
13.1.1. Middle East and Africa Saccharomyces Cerevisiae Revenue (USD Million) by Type (2021-2032)
13.1.2. Middle East and Africa Saccharomyces Cerevisiae Revenue (USD Million) by Application (2021-2032)
13.1.3. Middle East and Africa Saccharomyces Cerevisiae Revenue (USD Million) by Product (2021-2032)
By Type
Yeast Extracts
Yeast Autolysates
Yeast Beta-Glucan
Others
By Application
Food
Bakery
Functional Foods
Savory
Beverages
Feed
Others
Chapter 14. Saccharomyces Cerevisiae Company Profiles
14.1 Business Overview
14.2 Product Profiles
14.3 SWOT Profiles
14.5 Recent Developments
14.6 Financial Profile
List of Companies
AB Mauri
Algist Bruggeman
Alltech Inc
Angel Yeast
Bio-Strath
DCL Yeast
Kerry Group plc
Kothari Fermentation and Biochem
Lallemand
Leiber
Lesaffre Group
Ohly GmbH
Pakmaya
15. Methodology and Data Sources
15.1 Customization Offerings
15.2 Subscription Services
15.3 Related Reports
15.4 Publisher Expertise
LIST OF TABLES
Table 1 Market Segmentation Analysis
Table 2 Global Saccharomyces Cerevisiae Market Share of Leading Companies, 2023
Table 3 Product Offerings of Leading Companies
Table 4 Low Growth Scenario Forecasts
Table 5 Reference Case Growth Scenario
Table 6 High Growth Case Scenario
Table 7 Global Saccharomyces Cerevisiae Revenue (USD Million) And CAGR (%) By Type (2021-2032)
Table 8 Global Saccharomyces Cerevisiae Revenue (USD Million) And CAGR (%) By Application (2021-2032)
Table 9 Global Saccharomyces Cerevisiae Revenue (USD Million) And CAGR (%) By Product (2021-2032)
Table 10 Global Saccharomyces Cerevisiae Market Revenue (USD Million) By Regions (2021-2032)
Table 11 Global Saccharomyces Cerevisiae Market Share (%) By Regions (2021-2032)
Table 12 North America Saccharomyces Cerevisiae Revenue (USD Million) By Country (2021-2032)
Table 13 Europe Saccharomyces Cerevisiae Revenue (USD Million) By Country (2021-2032)
Table 14 Asia Pacific Saccharomyces Cerevisiae Revenue (USD Million) By Country (2021-2032)
Table 15 South America Saccharomyces Cerevisiae Revenue (USD Million) By Country (2021-2032)
Table 16 Middle East and Africa Saccharomyces Cerevisiae Revenue (USD Million) By Region (2021-2032)
Table 17 North America Saccharomyces Cerevisiae Revenue (USD Million) By Type (2021-2032)
Table 18 North America Saccharomyces Cerevisiae Revenue (USD Million) By Application (2021-2032)
Table 19 North America Saccharomyces Cerevisiae Revenue (USD Million) By Product (2021-2032)
Table 20 Europe Saccharomyces Cerevisiae Revenue (USD Million) By Type (2021-2032)
Table 21 Europe Saccharomyces Cerevisiae Revenue (USD Million) By Application (2021-2032)
Table 22 Europe Saccharomyces Cerevisiae Revenue (USD Million) By Product (2021-2032)
Table 23 Asia Pacific Saccharomyces Cerevisiae Revenue (USD Million) By Type (2021-2032)
Table 24 Asia Pacific Saccharomyces Cerevisiae Revenue (USD Million) By Application (2021-2032)
Table 25 Asia Pacific Saccharomyces Cerevisiae Revenue (USD Million) By Product (2021-2032)
Table 26 South America Saccharomyces Cerevisiae Revenue (USD Million) By Type (2021-2032)
Table 27 South America Saccharomyces Cerevisiae Revenue (USD Million) By Application (2021-2032)
Table 28 South America Saccharomyces Cerevisiae Revenue (USD Million) By Product (2021-2032)
Table 29 Middle East and Africa Saccharomyces Cerevisiae Revenue (USD Million) By Type (2021-2032)
Table 30 Middle East and Africa Saccharomyces Cerevisiae Revenue (USD Million) By Application (2021-2032)
Table 31 Middle East and Africa Saccharomyces Cerevisiae Revenue (USD Million) By Product (2021-2032)
LIST OF FIGURES
Figure 1. Market Scope
Figure 2. Pricing Forecasts Per Unit, 2023- 2032
Figure 3. Porter’s Five Forces
Figure 4. Global Saccharomyces Cerevisiae Market Revenue (USD Million) By Regions (2021-2032)
Figure 5. Global Saccharomyces Cerevisiae Market Share (%) By Regions (2023)
Figure 6. North America Saccharomyces Cerevisiae Revenue (USD Million) By Country (2021-2032)
Figure 7. United States Saccharomyces Cerevisiae Revenue (USD Million) By Country (2021-2032)
Figure 8. Canada Saccharomyces Cerevisiae Revenue (USD Million) By Country (2021-2032)
Figure 9. Mexico Saccharomyces Cerevisiae Revenue (USD Million) By Country (2021-2032)
Figure 10. Europe Saccharomyces Cerevisiae Revenue (USD Million) By Country (2021-2032)
Figure 11. Germany Saccharomyces Cerevisiae Revenue (USD Million) By Country (2021-2032)
Figure 12. France Saccharomyces Cerevisiae Revenue (USD Million) By Country (2021-2032)
Figure 13. United Kingdom Saccharomyces Cerevisiae Revenue (USD Million) By Country (2021-2032)
Figure 14. Spain Saccharomyces Cerevisiae Revenue (USD Million) By Country (2021-2032)
Figure 15. Italy Saccharomyces Cerevisiae Revenue (USD Million) By Country (2021-2032)
Figure 16. Russia Saccharomyces Cerevisiae Revenue (USD Million) By Country (2021-2032)
Figure 17. Rest of Europe Saccharomyces Cerevisiae Revenue (USD Million) By Country (2021-2032)
Figure 11. Asia Pacific Saccharomyces Cerevisiae Revenue (USD Million) By Country (2021-2032)
Figure 12. China Saccharomyces Cerevisiae Revenue (USD Million) By Country (2021-2032)
Figure 13. Japan Saccharomyces Cerevisiae Revenue (USD Million) By Country (2021-2032)
Figure 14. India Saccharomyces Cerevisiae Revenue (USD Million) By Country (2021-2032)
Figure 15. South Korea Saccharomyces Cerevisiae Revenue (USD Million) By Country (2021-2032)
Figure 16. Australia Saccharomyces Cerevisiae Revenue (USD Million) By Country (2021-2032)
Figure 17. South East Asia Saccharomyces Cerevisiae Revenue (USD Million) By Country (2021-2032)
Figure 18. South America Saccharomyces Cerevisiae Revenue (USD Million) By Country (2021-2032)
Figure 19. Brazil Saccharomyces Cerevisiae Revenue (USD Million) By Country (2021-2032)
Figure 20. Argentina Saccharomyces Cerevisiae Revenue (USD Million) By Country (2021-2032)
Figure 21. Rest of Asia Pacific Saccharomyces Cerevisiae Revenue (USD Million) By Country (2021-2032)
Figure 22. Middle East and Africa Saccharomyces Cerevisiae Revenue (USD Million) By Region (2021-2032)
Figure 23. Saudi Arabia Saccharomyces Cerevisiae Revenue (USD Million) By Region (2021-2032)
Figure 24. The UAE Saccharomyces Cerevisiae Revenue (USD Million) By Region (2021-2032)
Figure 25. Rest of Middle East Saccharomyces Cerevisiae Revenue (USD Million) By Region (2021-2032)
Figure 26. South Africa Saccharomyces Cerevisiae Revenue (USD Million) By Region (2021-2032)
Figure 27. Africa Saccharomyces Cerevisiae Revenue (USD Million) By Region (2021-2032)
Figure 28. North America Saccharomyces Cerevisiae Revenue (USD Million) By Type (2021-2032)
Figure 29. North America Saccharomyces Cerevisiae Revenue (USD Million) By Application (2021-2032)
Figure 30. North America Saccharomyces Cerevisiae Revenue (USD Million) By Product (2021-2032)
Figure 31. Europe Saccharomyces Cerevisiae Revenue (USD Million) By Type (2021-2032)
Figure 32. Europe Saccharomyces Cerevisiae Revenue (USD Million) By Application (2021-2032)
Figure 33. Europe Saccharomyces Cerevisiae Revenue (USD Million) By Product (2021-2032)
Figure 34. Asia Pacific Saccharomyces Cerevisiae Revenue (USD Million) By Type (2021-2032)
Figure 35. Asia Pacific Saccharomyces Cerevisiae Revenue (USD Million) By Application (2021-2032)
Figure 36. Asia Pacific Saccharomyces Cerevisiae Revenue (USD Million) By Product (2021-2032)
Figure 37. South America Saccharomyces Cerevisiae Revenue (USD Million) By Type (2021-2032)
Figure 38. South America Saccharomyces Cerevisiae Revenue (USD Million) By Application (2021-2032)
Figure 39. South America Saccharomyces Cerevisiae Revenue (USD Million) By Product (2021-2032)
Figure 40. Middle East and Africa Saccharomyces Cerevisiae Revenue (USD Million) By Type (2021-2032)
Figure 41. Middle East and Africa Saccharomyces Cerevisiae Revenue (USD Million) By Application (2021-2032)
Figure 42. Middle East and Africa Saccharomyces Cerevisiae Revenue (USD Million) By Product (2021-2032)
By Type
Yeast Extracts
Yeast Autolysates
Yeast Beta-Glucan
Others
By Application
Food
Bakery
Functional Foods
Savory
Beverages
Feed
Others
Countries Analyzed
North America (US, Canada, Mexico)
Europe (Germany, UK, France, Spain, Italy, Russia, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Australia, South East Asia, Rest of Asia)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)
Global Saccharomyces Cerevisiae Market Size is valued at $1.6 Billion in 2024 and is forecast to register a growth rate (CAGR) of 6.8% to reach $2.7 Billion by 2032.
Emerging Markets across Asia Pacific, Europe, and Americas present robust growth prospects.
AB Mauri, Algist Bruggeman, Alltech Inc, Angel Yeast, Bio-Strath, DCL Yeast, Kerry Group plc, Kothari Fermentation and Biochem, Lallemand, Leiber, Lesaffre Group, Ohly GmbH, Pakmaya
Base Year- 2023; Estimated Year- 2024; Historic Period- 2018-2023; Forecast period- 2024 to 2032; Currency: Revenue (USD); Volume